XT
SUPN icon

XTX Topco’s Supernus Pharmaceuticals SUPN Stock Holding History

XTX Topco’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
50,151
+24,525
+96% +$1.18M 0.03% 957
2026
Q1 		$1.32M Buy
+25,626
New +$1.3M 0.02% 1180
2025
Q4 		– Sell
-16,065
Closed -$768K – 3781
2025
Q3 		$768K Sell
16,065
-25,195
-61% -$1.01M 0.04% 748
2025
Q2 		$1.3M Buy
+41,260
New +$1.32M 0.05% 518
2025
Q1 		– Sell
-7,822
Closed -$283K – 3076
2024
Q4 		$283K Sell
7,822
-2,028
-21% -$71.4K 0.02% 1277
2024
Q3 		$307K Sell
9,850
-5,820
-37% -$182K 0.02% 1162
2024
Q2 		$419K Buy
+15,670
New +$454K 0.04% 748

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

XTX Topco's SUPN Position: Q2 2026 in Review

XTX Topco increased its Supernus Pharmaceuticals (SUPN) stake by 96% in Q2 2026, buying an estimated $1.18M and bringing the position to 50,151 shares worth $2.33M. The position accounts for 0.03% of the portfolio, ranked #957.

XTX Topco first reported a position in SUPN in Q2 2024 and has held it in 7 quarters since. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • XTX Topco held 50,151 shares of Supernus Pharmaceuticals worth $2.33M as of Q2 2026.
  • XTX Topco bought 24,525 Supernus Pharmaceuticals shares in Q2 2026, an estimated $1.18M.
  • Supernus Pharmaceuticals made up 0.03% of XTX Topco's portfolio in Q2 2026, its #957 holding.
  • XTX Topco first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.